There has been much talk of Bill Ackman losing his magic touch over his disastrous bets on Valeant Pharmaceuticals Intl Inc (NYSE: VRX), where he lost $4.6 billion, and his infamous short on Herbalife Ltd.(NYSE: HLF), which has gained 22 percent on the year and
U.S. regulators regard Herbalife Ltd. (NYSE: HLF) as a “multi-level marketing scheme,” but Bill Ackman is beyond euphemisms. To Ackman’s Pershing Square Holdings Ltd, the global nutrition company is a “pyramid scheme.”
Shares of Mondelez International Inc (NASDAQ: MDLZ) gained more than 1 percent early Monday morning after the Wall Street Journal reported Sunday that the snack-maker is looking to oust its CEO Irene Rosenfeld.
Valeant Pharmaceuticals Intl Inc (NYSE: VRX) plummeted 11 percent Tuesday after notable hedge fund manager Bill Ackman exited his large position of the pharmaceutical company at a loss that could be in the billions of dollars.
Herbalife Ltd. (NYSE: HLF) shares are up 2.3 percent Monday after Carl Icahn put to rest any speculation that he may be worried about his Herbalife investment ahead of the upcoming release of the “Betting On Zero” documentary.
Back in January, Benzinga published a series of articles where Don Steinbrugge, one of the top experts in the hedge fund industry, shared a preview of the top trends he expects to see among hedge funds in 2017.
Billionaire investor Carl Icahn's Icahn Enterprises LP (NASDAQ: IEP) announced last Wednesday the hiring of pharma academician Richard Mulligan as a portfolio manager. The announcement has set tongues wagging about Carl Icahn's renewed interest in the pharma/biotech sector.
Astute investors who have mastered the art and science of investing are an elite group to whom an average investor looks up to for portfolio modeling. Given the fickleness associated with the stock market, it's a tough proposition to continuously make money.
Shares of Hertz Global Holdings, Inc (NYSE: HTZ) were trading lower by nearly 4 percent early Friday morning after analysts at Credit Suisse downgraded the stock to Underperform from Neutral with a price target lowered to $15 from a previous $27.
Plenty of investors follow the smart money during 13-F filing season. If the managers running billion-dollar hedge funds are all buying or selling the same stock, it may serve as a strong indication that retail investors should be doing the same.